الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 52 |  |  |
| | | from | 52 | | |
Abstract
Malnutrition is a common problem in cancer patients and can increase the risk of adverse clinical events such as treatment related complications or death. As a result, it is important to assess every cancer patient’s nutritional status using one or more of the methods that are developed for this purpose.
Actually, there is no “gold standard” in diagnosis of malnutrition and a variety of clinical and biological methods can be used.
The current study was conducted to determine if serum prealbumin could be used to assess the nutritional status in patients with gynecological malignancy or not and also to detect the association between the prealbumin serum level and occurrence of the treatment related complications.
The study was conducted on 100 women diagnosed with gynecological malignancy.
The 100 studied cases were divided into two groups according to the nutritional status depending on the scored PG-SGA: group I (stage A, well-nourished) and group II (stage B, moderately malnourished and stage C, severely malnourished).
The results of the study can be summarized in these findings:
The prevalence of malnutrition among the studied cases with gynecological cancer was about 47 % as assessed by PG-SGA and most of malnourished cases were ovarian cancer (59.6 % of all malnourished cases).
There was significant correlation between the serum prealbumin level and the nutritional status as assessed by PG-SGA.
There was significant correlation between the serum prealbumin level and occurrence of complications after treatment.